IL1R1 and glomerulonephritis: In particular, in models of glomerulonephritis and unilateral ureteral obstruction, the administration of a specific IL-1R antagonist was able to inhibit the progression of functional damage and almost completely abrogated interstitial fibrosis/tubular atrophy (IF/TA) [25–27].